Shattuck Labs Inc (STTK)

NASDAQ
29.34
-0.37(-1.25%)
After Hours
29.34
0.00(0.00%)
- Real-time Data
  • Volume:
    494,114
  • Bid/Ask:
    23.77/30.50
  • Day's Range:
    27.69 - 30.18

STTK Overview

Prev. Close
29.71
Day's Range
27.69-30.18
Revenue
12.21M
Open
29.33
52 wk Range
17.51-60.52
EPS
-
Volume
494,114
Market Cap
1.23B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
191,963
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
41,904,619
Next Earnings Date
Sep 01, 2021
What is your sentiment on Shattuck Labs Inc?
or
Market is currently closed. Voting is open during market hours.

Shattuck Labs Inc News

Shattuck Labs Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralBuy
Technical IndicatorsBuyBuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyBuyBuy

Shattuck Labs Inc Company Profile

Shattuck Labs Inc Company Profile

Employees
59

Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of dual-sided fusion proteins. The Company has created an approach to immune modulation by designing biologics with structural characteristics. Compounds derived from its Agonist Redirected Checkpoint (ARC) platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the cluster of differentiation 47/signal regulatory protein alpha (CD47/SIRPa) checkpoint interaction to restore an anti-tumor immune response and to activate the cluster of differentiation 40 (CD40) costimulatory receptor to bolster an immune response. The Company's second product candidate, SL-279252, is designed to simultaneously inhibit the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction and activate the OX40 receptor.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.